Table 1 Baseline characteristics of study population
Characteristic | No PACU-OpResc (n = 743) | PACU-OpResc (n = 211) | |
|---|---|---|---|
Age (years) | 62.00 ± 13.34 | 58.93 ± 12.92 | |
Sex | Male | 321 (43.2%) | 97 (46.0%) |
Female | 422 (56.8%) | 114 (54.0%) | |
Height, cm | 167.77 ± 10.08 | 168.16 ± 10.12 | |
Weight, kg | 79.78 ± 22.15 | 77.66 ± 19.28 | |
BMI, kg/m2 | 28.20 ± 6.91 | 27.39 ± 6.03 | |
ASA Status | 1 | 14 (1.9%) | 1 (0.5%) |
2 | 218 (29.3%) | 58 (27.5%) | |
3 | 483 (65.0%) | 143 (67.8%) | |
4 | 28 (3.8%) | 9 (4.3%) | |
Surgical Service | General | 409 (55.0%) | 120 (56.9%) |
Gynecology | 146 (19.7%) | 28 (13.3%) | |
Not documented | 81 (10.9%) | 17 (8.1%) | |
Thoracic | 77 (10.4%) | 38 (18.0%) | |
Vascular | 21 (2.8%) | 6 (2.8%) | |
Orthopedics | 5 (0.7%) | 1 (0.5%) | |
Plastics | 4 (0.5%) | 1 (0.5%) | |
Duration of surgery, min | 267.00 (184.00, 393.00) | 258.00 (188.00, 384.00) | |
Work RVUs | 28.78 ± 14.48 | 27.71 ± 13.48 | |
High SPORC score | 26 (3.5%) | 5 (2.4%) | |
Preoperative opioid prescription* | 127 (17.1%) | 75 (35.5%) | |
Intraoperative morphine equivalent dose (mg) | 12.00 (10.00, 20.00) | 15.00 (10.00, 25.00) | |
PACU morphine equivalent dose (mg) | 0.00 (0.00, 0.00) | 5.00 (2.50, 7.50) | |
TEA Placement and management | |||
Placement in sitting position | 640 (86.1%) | 177 (83.9%) | |
Midline Approach | 322 (43.3%) | 87 (41.2%) | |
Documented local anesthetic bolus | 182 (24%) | 66 (31%) | |
First Case | 361 (48.6%) | 100 (47.4%) | |
Placement Attempts | 1 | 402 (54.1%) | 103 (48.8%) |
2 | 163 (21.9%) | 45 (21.3%) | |
≥3 | 88 (11.8%) | 38 (17.9%) | |
Not documented | 90 (12.1%) | 25 (11.8%) | |
Placement duration, min | 13.00 ± 8.30 | 13.72 ± 9.45 | |
Time from surgical Incision to TEA infusion start (minutes) | 27.60 ± 71.74 | 31.83 ± 74.59 | |
Epidural infusion during > 50% of case time | 603 (81.2%) | 146 (69.2%) | |